Literature DB >> 11289102

Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.

H Chaib1, M A Rubin, N R Mucci, L Li, M L Day, J S Rhim, J A Macoska.   

Abstract

Critical events in prostate tumorigenesis and metastasis likely include the abnormal activation and expression of specific genes. Using RNA expression profiling techniques, we have identified a transcript originating from the activated in prostate cancer (AIPC) gene, the expression of which is preferentially up-regulated in several cultured prostate tumor cell lines and human primary prostate tumors. Sequence analysis revealed that the AIPC protein encodes six PDZ domains, which are protein-protein binding domains likely involved in protein clustering and scaffolding. Immunohistochemical analysis of a tissue microarray comprising 158 tumor, 18 high-grade prostatic intraepithelial neoplasia, and 91 normal prostate specimens with an anti-AIPC antibody demonstrated abundant AIPC protein expression in 75% of tumors, 83% of prostatic intraepithelial neoplasia lesions, and 3% of normal tissues (P < 0.0001). These data suggest that the accumulation of AIPC protein may be closely associated with the initiation or early promotion of prostate tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289102

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  PDZ domains-glue and guide.

Authors:  Marco van Ham; Wiljan Hendriks
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

2.  Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

Authors:  Aykan A Karabudak; Julie Hafner; Vivekananda Shetty; Songming Chen; Angeles Alvarez Secord; Michael A Morse; Ramila Philip
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-03       Impact factor: 4.553

Review 3.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

4.  Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.

Authors:  Wenjin Chen; David J Foran
Journal:  Anal Chim Acta       Date:  2006-01-23       Impact factor: 6.558

5.  Survey of differentially methylated promoters in prostate cancer cell lines.

Authors:  Yipeng Wang; Qiuju Yu; Ann H Cho; Gaelle Rondeau; John Welsh; Eileen Adamson; Dan Mercola; Michael McClelland
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

6.  Classification of Homo sapiens gene behavior using linear discriminant analysis fused with minimum entropy mapping.

Authors:  Joyshri Das; Soma Barman Mandal
Journal:  Med Biol Eng Comput       Date:  2021-02-17       Impact factor: 2.602

7.  Proteolytic cleavage of PDZD2 generates a secreted peptide containing two PDZ domains.

Authors:  Man-Lung Yeung; Tammy S M Tam; Anthony C C Tsang; Kwok-Ming Yao
Journal:  EMBO Rep       Date:  2003-03-14       Impact factor: 8.807

8.  Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.

Authors:  S Manley; N R Mucci; A M De Marzo; M A Rubin
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

9.  PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle.

Authors:  Anna Santamaría; Pedro L Fernández; Xavier Farré; Patricia Benedit; Jaume Reventós; Juan Morote; Rosanna Paciucci; Timothy M Thomson
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

10.  Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.

Authors:  Ruibin Xi; Semin Lee; Yuchao Xia; Tae-Min Kim; Peter J Park
Journal:  Nucleic Acids Res       Date:  2016-06-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.